psoriasis

News

Johnson & Johnson’s psoriasis drug Tremfya has been given the green light for funding by cost-effectiveness bodies in the UK and Germany.

News

The US FDA has approved a label extension for UCB’s Cimzia (certolizumab pegol) for adults with moderate-to-severe plaque psoriasis

News

Escalier Biosciences, a privately-held biopharma company based in The Netherlands, has raised $19 million to help advance its pipeline.

News

Novartis is hoping that new real world data will help its psoriasis drug Cosentyx stay ahead of rivals.

News

AbbVie hopes risankizumab will rebuild sales after Humira patent expires

News

Thync's bioelectronic wearable significantly reduced symptoms in psoriasis patients within four weeks of use.